Effect of BCG vaccination on risk of Mycobacterium tuberculosis infection in children with household tuberculosis contact: A prospective community-based study

Lancet

Volumn 366, Issue 9495, 2005, Pages 1443-1451

  Soysal, Ahmet ^a   Millington, Kerry A ^b   Bakir, Mustafa ^a   Dosanjh, Davinder ^b   Aslan, Yasemin ^a   Deeks, Jonathan J ^c   Efe, Serpil ^a   Staveley, Imogen ^b   Ewer, Katie ^b   Lalvani, Ajit ^b  

^a MARMARA UNIVERSITY   (Turkey)

^b UNIVERSITY OF OXFORD   (United Kingdom)

^c UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

BCG VACCINE;

ADOLESCENT; AGE DISTRIBUTION; ARTICLE; BCG VACCINATION; CHILD; CLINICAL TRIAL; COMMUNITY CARE; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; ENZYME LINKED IMMUNOSPOT ASSAY; FEMALE; HUMAN; INFANT; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; MYCOBACTERIUM TUBERCULOSIS; NEWBORN; PRIORITY JOURNAL; PROSPECTIVE STUDY; RISK ASSESSMENT; SKIN TEST; THEORETICAL STUDY; TUBERCULOSIS; TURKEY (BIRD);

EID: 26944467583     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(05)67534-4     Document Type: Article

References (39)

1. T Gedde-Dahl Tuberculous infection in the light of tuberculin matriculation Am J Hyg 56 1952 139 214
2. C Lienhardt, K Fielding, J Sillah Risk factors for tuberculosis infection in sub-Saharan Africa: a contact study in The Gambia Am J Respir Crit Care Med 168 2003 448 455
3. A Lalvani, AA Pathan, H Durkan Enhanced contact tracing and spatial tracking of Mycobacterium tuberculosis infection by enumeration of antigen-specific T cells Lancet 357 2001 2017 2021
4. K Ewer, J Deeks, L Alvarez Comparison of T-cell-based assay with tuberculin skin test for diagnosis of Mycobacterium tuberculosis infection in a school tuberculosis outbreak Lancet 361 2003 1168 1173
5. S Grzybowski, GD Barnett, K Styblo Contacts of cases of active pulmonary tuberculosis Bull Int Union Tuberc 50 1975 90 106
6. R Narain, SS Nair, GR Rao, P Chandrasekhar Distribution of tuberculous infection and disease among households in a rural community Bull World Health Organ 34 1966 639 654
7. LM Almeida, MA Barbieri, AC Da Paixao, LE Cuevas Use of purified protein derivative to assess the risk of infection in children in close contact with adults with tuberculosis in a population with high Calmette-Guerin bacillus coverage Pediatr Infect Dis J 20 2001 1061 1065
8. C Lienhardt, J Sillah, K Fielding Risk factors for tuberculosis infection in children in contact with infectious tuberculosis cases in the Gambia, West Africa Pediatrics 111 2003 e608 e614
9. G Madico, RH Gilman, W Checkley Community infection ratio as an indicator for tuberculosis control Lancet 345 1995 416 419
10. L Wang, MO Turner, RK Elwood, M Schulzer, JM FitzGerald A meta-analysis of the effect of Bacille Calmette Guerin vaccination on tuberculin skin test measurements Thorax 57 2002 804 809
11. PE Fine, JA Sterne, JM Ponnighaus, RJ Rees Delayed-type hypersensitivity, mycobacterial vaccines and protective immunity Lancet 344 1994 1245 1249
12. GF Black, RE Weir, S Floyd BCG-induced increase in interferon-gamma response to mycobacterial antigens and efficacy of BCG vaccination in Malawi and the UK: two randomised controlled studies Lancet 359 2002 1393 1401
13. A Lalvani, AA Pathan, H McShane Rapid detection of Mycobacterium tuberculosis infection by enumeration of antigen-specific T cells Am J Respir Crit Care Med 163 2001 824 828
14. A Lalvani Spotting latent infection: the path to better tuberculosis control Thorax 58 2003 916 918
15. MA Behr, MA Wilson, WP Gill Comparative genomics of BCG vaccines by whole-genome DNA microarray Science 284 1999 1520 1523
16. M Harboe, T Oettinger, HG Wiker, I Rosenkrands, P Andersen Evidence for occurrence of the ESAT-6 protein in Mycobacterium tuberculosis and virulent Mycobacterium bovis and for its absence in Mycobacterium bovis BCG Infect Immun 64 1996 16 22
17. DW Smith, DN McMurray, EH Wiegeshaus, AA Grover, GE Harding Host-parasite relationships in experimental airborne tuberculosis. IV. Early events in the course of infection in vaccinated and nonvaccinated guinea pigs Am Rev Respir Dis 102 1970 937 949
18. WN Rom SM Garay Tuberculosis 1st edn. 1996 Little, Brown and Company New York
19. WHO World Health Organization Global TB database http://www.who.int/tb/ country/global_tb_database/en/index.html 2005 (accessed Sept 29, 2005)
20. WHO Immunization profile - Turkey http://www.who.int/ immunization_monitoring/en/globalsummary/countryprofileselect.cfm 2005 (accessed Sept 29, 2005)
21. L Richeldi, K Ewer, M Losi T cell-based tracking of multidrug resistant tuberculosis infection after brief exposure Am J Respir Crit Care Med 170 2004 288 295
22. J Zhang, KF Yu What's the relative risk? A method of correcting the odds ratio in cohort studies of common outcomes JAMA 280 1998 1690 1691
23. BE Neuenschwander, M Zwahlen, SJ Kim, EG Lee, HL Rieder Determination of the prevalence of infection with Mycobacterium tuberculosis among persons vaccinated against Bacillus Calmette-Guerin in South Korea Am J Epidemiol 155 2002 654 663
24. JJ Deeks, J Dinnes, R D'Amico Evaluating non-randomised intervention studies Health Technol Assess 7 2003 1 173
25. PE Fine, JM Ponnighaus, N Maine The distribution and implications of BCG scars in northern Malawi Bull World Health Org 67 1989 35 42
26. MR Sedaghatian, IA Shana'a Evaluation of BCG at birth in the United Arab Emirates Tubercle 71 1990 177 180
27. EM Santiago, E Lawson, K Gillenwater A prospective study of bacillus Calmette-Guerin scar formation and tuberculin skin test reactivity in infants in Lima, Peru Pediatrics 112 2003 e298
28. G Briassoulis, I Karabatsou, V Gogoglou, A Tsorva BCG vaccination at three different age groups: response and effectiveness J Immune Based Ther Vaccines 3 2005 1
29. TK Young, S Mirdad Determinants of tuberculin sensitivity in a child population covered by mass BCG vaccination Tuber Lung Dis 73 1992 94 100
30. H Aydinlioglu, S Caglayan, S Kansoy The decline of BCG immunity after neonatal vaccination: what about revaccination at one year? Paediatr Perinat Epidemiol 7 1993 334 338
31. HG ten Dam, KL Hitze Does BCG vaccination protect the newborn and young infants? Bull World Health Organ 58 1980 37 41
32. GA Colditz, TF Brewer, CS Berkey Efficacy of BCG vaccine in the prevention of tuberculosis. Meta-analysis of the published literature JAMA 271 1994 698 702
33. LC Rodrigues, VK Diwan, JG Wheeler Protective effect of BCG against tuberculous meningitis and miliary tuberculosis: a meta-analysis Int J Epidemiol 22 1993 1154 1158
34. NP Goonetilleke, H McShane, CM Hannan, RJ Anderson, RH Brookes, AV Hill Enhanced immunogenicity and protective efficacy against Mycobacterium tuberculosis of bacille Calmette-Guerin vaccine using mucosal administration and boosting with a recombinant modified vaccinia virus Ankara J Immunol 171 2003 1602 1609
35. HM Vordermeier, MA Chambers, PJ Cockle, AO Whelan, J Simmons, RG Hewinson Correlation of ESAT-6-specific gamma interferon production with pathology in cattle following Mycobacterium bovis BCG vaccination against experimental bovine tuberculosis Infect Immun 70 2002 3026 3032
36. H McShane, AA Pathan, CR Sander Recombinant modified vaccinia virus Ankara expressing antigen 85A boosts BCG-primed and naturally acquired antimycobacterial immunity in humans Nat Med 10 2004 1240 1244
37. M Pai, LW Riley, JM Colford Jr Interferon-γ assays in the immunodiagnosis of tuberculosis: a systematic review Lancet Infect Dis 4 2004 761 776
38. CC Leung, T Li, TH Lam Smoking and tuberculosis among the elderly in Hong Kong Am J Respir Crit Care Med 170 2004 1027 1033
39. V Gajalakshmi, R Peto, TS Kanaka, P Jha Smoking and mortality from tuberculosis and other diseases in India: retrospective study of 43 000 adult male deaths and 35 000 controls Lancet 362 2003 507 515